HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toxicological evaluation of naringin: Acute, subchronic, and chronic toxicity in Beagle dogs.

Abstract
Naringin is a type of bioflavonoid widely found in a lot of dietary products. Our previous studies revealed that naringin was practically non-toxic for SD rats in an oral acute toxicity study and the no-observed-adverse-effect-level (NOAEL) in SD rats was greater than 1250 mg/kg/day when administered by oral gavage for 13 consecutive weeks or 6 consecutive months. Herein we assessed the safety of naringin in Beagle dogs. Acute oral administration of naringin was done as a single bolus dose up to 5 g/kg. Subchronic toxicity study for 3 months and chronic toxicity study for 6 months were done by oral administration at doses of 0 (control), 20, 100, and 500 mg/kg. The LD50 dosage level for dogs was determined to be > 5 g/kg body weight. In the repeated-dose 3-month and 6-month oral toxicity studies, no morbidity, mortality, and toxicologically relevant events were observed either during dosing or the post-dosing recovery period. It was concluded that the NOAEL of naringin in Beagle dogs is at least 500 mg/kg body weight per day when administered orally for 3 and 6 consecutive months. These results, combined with the previous toxicological studies in rats, demonstrate a good safety profile of naringin.
AuthorsPeibo Li, Hao Wu, Yonggang Wang, Wei Peng, Weiwei Su
JournalRegulatory toxicology and pharmacology : RTP (Regul Toxicol Pharmacol) Vol. 111 Pg. 104580 (Mar 2020) ISSN: 1096-0295 [Electronic] Netherlands
PMID31954754 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Flavanones
  • naringin
Topics
  • Administration, Oral
  • Animals
  • Citrus (chemistry)
  • Dogs
  • Female
  • Flavanones (administration & dosage, isolation & purification, toxicity)
  • Male
  • No-Observed-Adverse-Effect Level
  • Toxicity Tests, Acute
  • Toxicity Tests, Subchronic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: